Doxycycline Hyclate
NDC Package 85477-501-05
Package Information
Doxycycline Hyclate is a medication used to treat a wide variety of bacterial infections, including those that cause acne. Marketed by Oncora Pharma, Llc, this product is identified by NDC 85477-501 and is authorized under FDA application ANDA210664.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85477 - Oncora Pharma, Llc
- 85477-501 - Doxycycline Hyclate
- 85477-501-05 - 500 TABLET, COATED in 1 BOTTLE
- 85477-501 - Doxycycline Hyclate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85477-501-05 identifies a specific commercial package of 500 tablet, coated in 1 bottle of Doxycycline Hyclate, labeled by Oncora Pharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 500 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Oncora Pharma, Llc on August 21, 2020. The current certification is valid through March 01, 2026.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Oncora Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85477050105. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.